Trials / Terminated
TerminatedNCT00577395
Bone Microarchitecture in Osteopenic Postmenopausal Women
A 12-month, Multicenter, Double-blind, Randomized, Parallel Group Study Comparing 150 mg Once-a-month Risedronate and Placebo Using 3-dimensional Micro MRI (Magnetic Resonance Imaging).
- Status
- Terminated
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 13 (actual)
- Sponsor
- Warner Chilcott · Industry
- Sex
- Female
- Age
- 40 Years – 57 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this trial is to compare the difference in bone microarchitecture of the distal radius at month 12 in postmenopausal osteopenic women treated with risedronate 150mg taken once a month compared to placebo.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | placebo | oral tablet once a month for 12 months |
| DRUG | risedronate | tablet, 150 mg once a month for 12 months |
Timeline
- Start date
- 2008-07-01
- Primary completion
- 2009-02-01
- Completion
- 2009-02-01
- First posted
- 2007-12-20
- Last updated
- 2013-04-22
- Results posted
- 2009-12-22
Locations
4 sites across 2 countries: United States, Argentina
Source: ClinicalTrials.gov record NCT00577395. Inclusion in this directory is not an endorsement.